No Pain More Gain

Description

NPMG Cream is a topical formulation designed for dermatological use. It is presented in a cream dosage form, facilitating easy application to the skin. The specific composition and inactive ingredients of NPMG Cream contribute to its intended therapeutic effects. The cream exhibits a smooth texture and is formulated to ensure optimal absorption and efficacy upon application.

Uses and Indications

This drug is indicated for the treatment of pain and as a preventive measure. It is particularly effective for application on large areas of the body. The formulation provides temporary yet long-lasting pain relief while also moisturizing the skin. Utilizing an advanced German formula, this product begins to take effect upon contact, penetrating deeply and absorbing quickly. Additionally, it is characterized by a fresh and pleasant scent.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

Healthcare professionals should instruct patients to shake the product well before use. For adults and children aged 2 years and older, the recommended application is to the affected areas up to six times a day. It is important to massage the product gently into the skin to ensure proper absorption and effectiveness.

Contraindications

There are no specific contraindications listed for this product. However, it is advised to discontinue use and consult a healthcare professional if any of the following occur: worsening of the condition, skin irritation, or if symptoms persist for more than 7 days or resolve and then recur within a few days.

Warnings and Precautions

For external use only. It is imperative to avoid contact with the eyes and mucous membranes to prevent irritation or injury. The product should not be used in conjunction with a heating pad, as this may lead to adverse effects. Additionally, application on open wounds or broken skin is contraindicated, as it may exacerbate the condition or lead to infection.

Patients should be advised to discontinue use and consult a healthcare professional if any of the following occur: worsening of the condition, development of skin irritation, or if symptoms persist for more than 7 days. If symptoms resolve and then recur within a few days, medical advice should also be sought.

While no specific emergency medical instructions are provided, it is essential for patients to be aware of the need for immediate medical attention if they experience severe reactions or complications.

Currently, there are no specific laboratory tests recommended for monitoring the use of this product. However, healthcare professionals should remain vigilant for any signs of adverse reactions or complications that may necessitate further evaluation.

Side Effects

Patients should be aware that the product is intended for external use only. It is crucial to avoid contact with the eyes and mucous membranes, as this may lead to irritation or adverse effects. Additionally, the product should not be used in conjunction with a heating pad, nor should it be applied to open wounds or broken skin.

In the event that the condition worsens, skin irritation occurs, or symptoms persist for more than 7 days, or if symptoms clear up and then recur within a few days, patients are advised to discontinue use and consult a healthcare professional. These precautions are essential to ensure the safe and effective use of the product.

Drug Interactions

No specific drug interactions have been identified in the available data. Additionally, there are no reported interactions between the drug and laboratory tests. As such, no dosage adjustments or monitoring recommendations are necessary based on drug interactions.

Packaging & NDC

Below are the non-prescription pack sizes of No Pain More Gain (menthol). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be kept out of reach of children. For those aged 2 years and older, the recommended application is to the affected areas up to 6 times a day.

Geriatric Use

There is no specific information available regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. It is advisable to monitor these patients closely for any adverse effects or changes in efficacy.

Pregnancy

There is no specific information available regarding the use of this medication during pregnancy. The prescribing information does not include any statements concerning safety concerns for pregnant patients. Additionally, there are no dosage modifications recommended for individuals who are pregnant, nor are there any special precautions outlined for use during this period. Healthcare professionals should consider the absence of data when prescribing this medication to women of childbearing potential and weigh the potential risks and benefits.

Lactation

There are no specific warnings or recommendations regarding the use of this product in nursing mothers. Additionally, there is no information available about the potential for excretion in breast milk or any associated risks to breastfed infants.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available prescribing information. There are no dosage adjustments, special monitoring requirements, or safety considerations outlined for individuals with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of data when prescribing to this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the absence of specific information regarding overdosage, healthcare professionals are advised to exercise caution and adhere to general principles of management in cases of suspected overdose.

It is essential to monitor the patient closely for any potential symptoms that may arise from an overdose. Symptoms can vary widely depending on the substance involved and the individual patient's response.

In the event of an overdose, the following management procedures are recommended:

1. Assessment: Conduct a thorough assessment of the patient's clinical status, including vital signs and level of consciousness.

2. Supportive Care: Provide supportive care as needed, which may include airway management, oxygen supplementation, and intravenous fluids.

3. Consultation: Consider consulting a poison control center or a medical toxicologist for guidance on specific interventions and antidotes, if applicable.

4. Documentation: Document all findings, interventions, and the patient's response to treatment meticulously.

Healthcare professionals should remain vigilant and prepared to implement appropriate measures based on the clinical presentation of the patient.

Nonclinical Toxicology

No information is available regarding teratogenic or non-teratogenic effects. Additionally, there is no data provided concerning nonclinical toxicology, animal pharmacology, or toxicology.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to keep the medication out of reach of children to prevent accidental ingestion.

Patients should be instructed to stop using the product and consult a doctor if any of the following occur: the condition worsens, skin irritation develops, or if symptoms persist for more than 7 days. Additionally, patients should be informed to seek medical advice if symptoms clear up and then recur within a few days.

Storage and Handling

The product is supplied in a configuration that ensures optimal usability. It should be stored at room temperature, away from direct sunlight and moisture. To maintain its efficacy, it is essential to keep the product out of reach of children. Prior to use, the container must be shaken well to ensure proper mixing of the contents. It is important to note that the product should not be frozen, as this may compromise its integrity and effectiveness.

Additional Clinical Information

The medication is administered topically, with a recommended application frequency of up to six times a day for adults and children aged 2 years and older, specifically to the affected areas. There are no additional details available regarding laboratory tests, abuse information, patient counseling, or postmarketing experience.

Drug Information (PDF)

This file contains official product information for No Pain More Gain, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)